✦ LIBER ✦

Surface warfare against pathogens using mucosal vaccines

✍ Scribed by Clements, John D.

Book ID: 109905744
Publisher: Nature Publishing Group
Year: 1997
Tongue: English
Weight: 347 KB
Volume: 15
Category: Article
ISSN: 1087-0156
DOI: 10.1038/nbt0797-622

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Fc receptor-targeted mucosal vaccination

Fc receptor-targeted mucosal vaccination as a novel strategy for the generation of enhanced immunity against mucosal and non-mucosal pathogens

✍ Edmund J. Gosselin; Constantine Bitsaktsis; Ying Li; Bibiana V. Iglesias 📂 Article 📅 2009 🏛 Springer 🌐 English ⚖ 240 KB

Vaccination of vervet monkeys against cu

Vaccination of vervet monkeys against cutaneous leishmaniosis using recombinant Leishmania ‘major surface glycoprotein’ (gp63)

✍ J.O. Olobo; C.O. Anjili; M.M. Gicheru; P.A. Mbati; T.M. Kariuki; J.I. Githure; D 📂 Article 📅 1995 🏛 Elsevier Science 🌐 English ⚖ 858 KB

Systemic and mucosal immunity induced by

Systemic and mucosal immunity induced by oral somatic transgene vaccination against glycoprotein B of pseudorabies virus using live attenuated Salmonella typhimurium

✍ Seong-Kug Eo; Hyun-A Yoon; Abi George Aleyas; Seong-Ok Park; Young-Woo Han; Joon 📂 Article 📅 2006 🏛 John Wiley and Sons 🌐 English ⚖ 234 KB

A surface-displayed cholera toxin B pept

A surface-displayed cholera toxin B peptide improves antibody responses using food-grade staphylococci for mucosal subunit vaccine delivery

✍ François Cano; Sissela Liljeqvist; Thien N. Nguyen; Patrik Samuelson; Jean-Yves 📂 Article 📅 1999 🏛 John Wiley and Sons 🌐 English ⚖ 278 KB

Cell surface display of highly pathogeni

Cell surface display of highly pathogenic avian influenza virus hemagglutinin on the surface of Pichia pastoris cells using α-agglutinin for production of oral vaccines

✍ Jamie L. Wasilenko; Luciana Sarmento; Stephen Spatz; Mary Pantin-Jackwood 📂 Article 📅 2009 🏛 American Institute of Chemical Engineers 🌐 English ⚖ 235 KB

Development of a nasal vaccine for chron

Development of a nasal vaccine for chronic hepatitis B infection that uses the ability of hepatitis B core antigen to stimulate a strong Th1 response against hepatitis B surface antigen

✍ Aguilar, JC; Lobaina, Y; Muzio, V; Garcia, D; Penton, E; Iglesias, E; Pichardo, 📂 Article 📅 2004 🏛 Nature Publishing Group 🌐 English ⚖ 392 KB